Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Convergence of risk prediction models in follicular lymphoma.

Silva A, Bassim S, Sarkozy C, Mottok A, Lackraj T, Jurinovic V, Brodtkorb M, Lingjaerde OC, Sehn LH, Gascoyne RD, Weigert O, Steidl C, Kridel R.

Haematologica. 2019 Jan 3. pii: haematol.2018.209031. doi: 10.3324/haematol.2018.209031. [Epub ahead of print]

2.

Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA.

Sarkozy C, Copie-Bergman C, Damotte D, Ben-Neriah S, Burroni B, Cornillon J, Lemal R, Golfier C, Fabiani B, Chassagne-Clément C, Parrens M, Herbaux C, Xerri L, Bossard C, Laurent C, Cheminant M, Cartron G, Cabecadas J, Molina T, Salles G, Steidl C, Ghesquières H, Mottok A, Traverse-Glehen A.

Am J Surg Pathol. 2019 Mar;43(3):341-351. doi: 10.1097/PAS.0000000000001198.

PMID:
30540571
3.

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts.

Sarkozy C, Maurer MJ, Link BK, Ghesquieres H, Nicolas E, Thompson CA, Traverse-Glehen A, Feldman AL, Allmer C, Slager SL, Ansell SM, Habermann TM, Bachy E, Cerhan JR, Salles G.

J Clin Oncol. 2019 Jan 10;37(2):144-152. doi: 10.1200/JCO.18.00400. Epub 2018 Nov 27.

4.

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management.

Bal A, Sarkozy C, Josset L, Cheynet V, Oriol G, Becker J, Vilchez G, Sesques P, Mallet F, Pachot A, Morfin F, Lina B, Salles G, Reynier F, Trouillet-Assant S, Brengel-Pesce K.

Viruses. 2018 Nov 14;10(11). pii: E633. doi: 10.3390/v10110633.

5.

Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.

Lemonnier F, Dupuis J, Sujobert P, Tournillhac O, Cheminant M, Sarkozy C, Pelletier L, Marçais A, Robe C, Fataccioli V, Haioun C, Hermine O, Gaulard P, Delarue R.

Blood. 2018 Nov 22;132(21):2305-2309. doi: 10.1182/blood-2018-04-840538. Epub 2018 Oct 2. No abstract available.

PMID:
30279227
6.

Management of relapsed/refractory DLBCL.

Sarkozy C, Sehn LH.

Best Pract Res Clin Haematol. 2018 Sep;31(3):209-216. doi: 10.1016/j.beha.2018.07.014. Epub 2018 Jul 23. Review.

PMID:
30213390
7.

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association.

Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31.

8.

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.

Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium.

Lancet Haematol. 2018 Aug;5(8):e359-e367. doi: 10.1016/S2352-3026(18)30090-5. Epub 2018 Jul 4.

PMID:
30078408
9.

Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.

Filliatre-Clement L, Maucort-Boulch D, Bourbon E, Karlin L, Safar V, Bachy E, Sesques P, Ferrant E, Bouafia F, Lazareth A, Ghergus D, Coiffier B, Traverse Glehen A, Salles G, Ghesquieres H, Sarkozy C.

Hematol Oncol. 2018 May 2. doi: 10.1002/hon.2512. [Epub ahead of print]

PMID:
29722049
10.

Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

Ranchon F, Vantard N, Henin E, Bachy E, Sarkozy C, Karlin L, Bouafia-Sauvy F, Gouraud A, Schwiertz V, Bourbon E, Baudouin A, Caffin AG, Vial T, Salles G, Rioufol C.

Hematol Oncol. 2018 Apr;36(2):399-406. doi: 10.1002/hon.2479. Epub 2017 Oct 6.

PMID:
28983943
11.

Diffuse large B-cell lymphoma (DLBCL), 2 versus 3: end of a debate?

Sarkozy C, Coiffier B.

Ann Oncol. 2017 Jul 1;28(7):1411-1413. doi: 10.1093/annonc/mdx249. No abstract available.

PMID:
28481969
12.

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.

Sarkozy C, Huet S, Carlton VE, Fabiani B, Delmer A, Jardin F, Delfau-Larue MH, Hacini M, Ribrag V, Guidez S, Faham M, Salles G.

Oncotarget. 2017 Jan 31;8(5):8765-8774. doi: 10.18632/oncotarget.14448.

13.

Diffuse large B-cell lymphoma: R-CHOP failure-what to do?

Coiffier B, Sarkozy C.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):366-378. Review.

14.

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.

Sarkozy C, Kaltenbach S, Faurie P, Canioni D, Berger F, Traverse-Glehen A, Ghesquieres H, Salles G, Bachy E, Alyanakian MA, Hermine O, Neven B, Macintyre E, Romana S, Molina TJ, Suarez F, Asnafi V, Bruneau J.

Genes Chromosomes Cancer. 2017 Mar;56(3):221-230. doi: 10.1002/gcc.22428. Epub 2016 Nov 1.

PMID:
27750397
15.

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.

Sarkozy C, Molina T, Ghesquières H, Michallet AS, Dupuis J, Damotte D, Morsschauser F, Parrens M, Martin L, Dartigues P, Stamatoullas A, Hirsch P, Fabiani B, Bouabdallah K, da Silva MG, Maerevoet M, Laurent C, Coiffier B, Salles G, Traverse-Glehen A.

Haematologica. 2017 Jan;102(1):150-159. doi: 10.3324/haematol.2016.152256. Epub 2016 Oct 6.

16.

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

Maurer MJ, Bachy E, Ghesquières H, Ansell SM, Nowakowski GS, Thompson CA, Inwards DJ, Allmer C, Chassagne-Clément C, Nicolas-Virelizier E, Sebban C, Lebras L, Sarkozy C, Macon WR, Feldman AL, Syrbu SI, Traverse-Glehan A, Coiffier B, Slager SL, Weiner GJ, Witzig TE, Habermann TM, Salles G, Cerhan JR, Link BK.

Am J Hematol. 2016 Nov;91(11):1096-1101. doi: 10.1002/ajh.24492. Epub 2016 Sep 3.

17.

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.

Tixier F, Ranchon F, Iltis A, Vantard N, Schwiertz V, Bachy E, Bouafia-Sauvy F, Sarkozy C, Tournamille JF, Gyan E, Salles G, Rioufol C.

Hematol Oncol. 2017 Dec;35(4):584-590. doi: 10.1002/hon.2328. Epub 2016 Jul 5.

PMID:
27377614
18.

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

Sarkozy C, Trneny M, Xerri L, Wickham N, Feugier P, Leppa S, Brice P, Soubeyran P, Gomes Da Silva M, Mounier C, Offner F, Dupuis J, Caballero D, Canioni D, Paula M, Delarue R, Zachee P, Seymour J, Salles G, Tilly H.

J Clin Oncol. 2016 Aug 1;34(22):2575-82. doi: 10.1200/JCO.2015.65.7163. Epub 2016 Jun 13. Erratum in: J Clin Oncol. 2016 Sep 10;34(26):3230.

PMID:
27298402
19.

FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.

Dubreuil J, Moreau A, Sarkozy C, Traverse-Glehen A, Skanjeti A, Salles G, Giammarile F.

Clin Nucl Med. 2016 May;41(5):397-8. doi: 10.1097/RLU.0000000000001111.

PMID:
26825213
20.

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program.

Perrot A, Monjanel H, Bouabdallah R, Quittet P, Sarkozy C, Bernard M, Stamatoullas A, Borel C, Bouabdallah K, Nicolas-Virelizier E, Fournier M, Morschhauser F, Brice P; Lymphoma Study Association (LYSA).

Haematologica. 2016 Apr;101(4):466-73. doi: 10.3324/haematol.2015.134213. Epub 2016 Jan 14.

21.

Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.

Sarkozy C, Traverse-Glehen A, Coiffier B.

Lancet Oncol. 2015 Nov;16(15):e555-e567. doi: 10.1016/S1470-2045(15)00005-4. Review.

PMID:
26545844
22.

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.

Mestrallet F, Sujobert P, Sarkozy C, Traverse-Glehen A, Callet-Bauchu E, Magaud JP, Salles G, Baseggio L.

Cytometry B Clin Cytom. 2016 Sep;90(5):433-9. doi: 10.1002/cyto.b.21331. Epub 2015 Dec 11.

23.

Primary refractory diffuse large B cell lymphoma in the rituximab era.

Sarkozy C, Coiffier B.

Curr Opin Oncol. 2015 Sep;27(5):377-83. doi: 10.1097/CCO.0000000000000209. Review.

PMID:
26258271
24.

The biology of aging and lymphoma: a complex interplay.

Sarkozy C, Salles G, Falandry C.

Curr Oncol Rep. 2015 Jul;17(7):32. doi: 10.1007/s11912-015-0457-x. Review.

PMID:
26003736
25.

Chemotherapy-free treatment in patients with follicular lymphoma.

Sarkozy C, Salles G, Bachy E.

Expert Rev Hematol. 2015 Apr;8(2):187-203. doi: 10.1586/17474086.2015.998995. Epub 2015 Jan 13. Review.

PMID:
25585961
26.

Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era.

Sarkozy C, Camus V, Tilly H, Salles G, Jardin F.

Leuk Lymphoma. 2015 Jul;56(7):1959-68. doi: 10.3109/10428194.2014.979412. Epub 2015 Jan 21. Review.

PMID:
25363401
27.

Haematological cancer: the translocation behind follicular lymphoma development.

Sarkozy C, Coiffier B.

Nat Rev Clin Oncol. 2014 Aug;11(8):444-5. doi: 10.1038/nrclinonc.2014.100. Epub 2014 Jun 17. No abstract available.

PMID:
24935014
28.

Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma.

Sarkozy C, Seymour JF, Ferme C, Caballero D, Ghesquieres H, Leppa S, Delarue R, Pedersen LM, Mounier C, Gomes Da Silva M, Chassagne-Clement C, Maerevoet M, Salles G.

Blood. 2014 Apr 24;123(17):2740-2. doi: 10.1182/blood-2014-02-553693. No abstract available.

29.

Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.

Sicard A, Karras A, Goujon JM, Sirac C, Bender S, Labatut D, Callard P, Sarkozy C, Essig M, Vanhille P, Provot F, Nony A, Nochy D, Ronco P, Bridoux F, Touchard G.

Nephrol Dial Transplant. 2014 Oct;29(10):1894-902. doi: 10.1093/ndt/gfu045. Epub 2014 Mar 11.

PMID:
24619059
30.

Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.

Pilorge S, Rigaudeau S, Rabian F, Sarkozy C, Taksin AL, Farhat H, Merabet F, Ghez S, Raggueneau V, Terré C, Garcia I, Renneville A, Preudhomme C, Castaigne S, Rousselot P.

Am J Hematol. 2014 Apr;89(4):399-403. doi: 10.1002/ajh.23653. Epub 2014 Mar 7.

31.

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.

Sarkozy C, Baseggio L, Feugier P, Callet-Bauchu E, Karlin L, Seymour JF, Lebras L, Michallet AS, Offner F, Dumas O, Traverse-Glehen A, Ffrench M, Lopez-Guillermo A, Berger F, Coiffier B, Felman P, Salles G.

Br J Haematol. 2014 Mar;164(5):659-67. doi: 10.1111/bjh.12675. Epub 2013 Nov 26.

PMID:
24274024
32.

Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.

Sarkozy C, Terré C, Jardin F, Radford I, Roche-Lestienne C, Penther D, Bastard C, Rigaudeau S, Pilorge S, Morschhauser F, Bouscary D, Delarue R, Farhat H, Rousselot P, Hermine O, Tilly H, Chevret S, Castaigne S.

Genes Chromosomes Cancer. 2014 Jan;53(1):106-16. doi: 10.1002/gcc.22123. Epub 2013 Oct 29.

PMID:
24249260
33.

Treatment approaches to asymptomatic follicular lymphoma.

Sarkozy C, Salles G.

Expert Rev Hematol. 2013 Dec;6(6):747-58. doi: 10.1586/17474086.2013.860355. Review.

PMID:
24219551
34.

Outcome of older patients with acute myeloid leukemia in first relapse.

Sarkozy C, Gardin C, Gachard N, Merabet F, Turlure P, Malfuson JV, Pautas C, Micol JB, Thomas X, Quesnel B, Celli-Lebras K, Preudhomme C, Terré C, Fenaux P, Chevret S, Castaigne S, Dombret H.

Am J Hematol. 2013 Sep;88(9):758-64. doi: 10.1002/ajh.23498. Epub 2013 Aug 7.

35.

Diffuse large B-cell lymphoma in the elderly: a review of potential difficulties.

Sarkozy C, Coiffier B.

Clin Cancer Res. 2013 Apr 1;19(7):1660-9. doi: 10.1158/1078-0432.CCR-12-2837. Epub 2013 Jan 21. Review.

36.

Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient.

Izzedine H, Kheder-Elfekih R, Housset P, Sarkozy C, Brocheriou I, Deray G.

AIDS. 2009 Feb 20;23(4):544-5. doi: 10.1097/QAD.0b013e32832407f7. No abstract available.

PMID:
19165085

Supplemental Content

Loading ...
Support Center